Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Oct 26;290(51):30607–30615. doi: 10.1074/jbc.M115.681627

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

PMC Copyright notice

FIGURE 4. — Overexpression of FOXP1 in the liver of DIO mice inhibits hepatic gluconeogenesis and improves glucose intolerance. Male DIO mice were injected with Ad-GFP of Ad-FOXP1 as described under “Experimental Procedures.” A, real-time PCR analysis of mRNA levels of FOXP1, PEPCK, G6PC, and PGC-1α in the liver of Ad-GFP or Ad-FOXP1-injected DIO mice (n = 6 each group). B, Western blotting analysis of protein levels of FOXP1, PEPCK, and α-Tubulin in the liver of Ad-GFP or Ad-FOXP1 injected DIO mice (n = 6 each group). C, fasting (6 h) blood glucose levels of DIO mice on day 5 after injection with the indicated adenovirus (n = 6 each group). D, pyruvate tolerance test (n = 6 each group). E, glucose tolerance test (n = 6 each group). *, p < 0.05; **, p < 0.01, mice injected with Ad-GFP versus mice injected with Ad-FOXP1.